Table 1.
Subject characteristics (n = 42)
| Characteristic | Value |
|---|---|
| Sex | |
| Male | 23 (54.8) |
| Female | 19 (45.2) |
| Current age (yr) | 11 ± 3 |
| Age at diagnosis (yr) | 3 (0.5-8) |
| Time since diagnosis (yr) | 8 ± 3 |
| ART duration (yr) | 8 (3-14) |
| Type of ART | |
| Lamivudine | 42 (100.0) |
| Zidovudine | 38 (90.5) |
| Tenofovir | 6 (14.3) |
| Nevirapine | 21 (50.0) |
| Efavirenz | 19 (45.2) |
| Lopinavir/Ritonavir | 2 (4.8) |
| Nutritional status | |
| Normal | 33 (78.6) |
| Moderate malnutrition | 6 (14.3) |
| Severe malnutrition | 3 (7.1) |
| Clinical stage at diagnosis (n = 40) | |
| I | 5 (12.5) |
| II | 9 (22.5) |
| III | 13 (32.5) |
| IV | 13 (32.5) |
Data are presented as number (%), mean ± standard deviation, or median (minimum-maximum).
ART, antiretroviral therapy.